Benzinga | Aug 9, 2021 04:16PM EDT

FibroGen Q2 EPS $(1.45) Down From $(0.95) YoY, Sales $4.36M Down From $42.89M YoY

FibroGen (NASDAQ:FGEN) reported quarterly losses of $(1.45) per share. This is a 52.63 percent decrease over losses of $(0.95) per share from the same period last year. The company reported $4.36 million in sales this quarter. This is a 89.82 percent decrease over sales of $42.89 million the same period last year.